Evidence map›Paper›PMID 30544868›Full record

ReviewPharmaceutics2018

The Microfluidic Technique and the Manufacturing of Polysaccharide Nanoparticles.

Enrica Chiesa, Rossella Dorati, Silvia Pisani, Bice Conti, Gloria Bergamini, Tiziana Modena, Ida Genta

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Selection of natural biomaterials for micro-tissue and organ-on-chip models.Journal of biomedical materials research. Part A · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Enrica ChiesaDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. enrica.chiesa01@universitadipavia.it.
Rossella DoratiDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. rossella.dorati@unipv.it.
Silvia PisaniDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. silvia.pisani01@universitadipavia.it.
Bice ContiDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. bice.conti@unipv.it.ORCID 0000-0002-0034-2815
Gloria BergaminiDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. gloria.bergamini01@universitadipavia.it.
Tiziana ModenaDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. tiziana.modena@unipv.it.
Ida GentaDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. ida.genta@unipv.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microfluidic technique has emerged as a promising tool to accelerate the clinical translation of nanoparticles, and its application affects several aspects, such as the production of nanoparticles and the in vitro characterization in the microenvironment, mimicking in vivo conditions. This review covers the general aspects of the microfluidic technique and its application in several fields, such as the synthesis, recovering, and samples analysis of nanoparticles, and in vitro characterization and their in vivo application. Among these, advantages in the production of polymeric nanoparticles in a well-controlled, reproducible, and high-throughput manner have been highlighted, and detailed descriptions of microfluidic devices broadly used for the synthesis of polysaccharide nanoparticles have been provided. These nanoparticulate systems have drawn attention as drug delivery vehicles over many years; nevertheless, their synthesis using the microfluidic technique is still largely unexplored. This review deals with the use of the microfluidic technique for the synthesis of polysaccharide nanoparticles; evaluating features of the most studied polysaccharide drug carriers, such as chitosan, hyaluronic acid, and alginate polymers. The critical assessment of the most recent research published in literature allows us to assume that microfluidics will play an important role in the discovery and clinical translation of nanoplatforms.

Indexed as

alginatechitosanhyaluronic acidmicrofluidicnanoparticle productionpolysaccharide nanoparticles

Identifiers

PMID30544868
PMCPMC6321127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.